| - SMTL ID
- 4ele.1
- Ligands
- CALCIUM ION; CHLORIDE ION; (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(propan-2-yl)phthalazin-2(1H)-yl]prop-2-en -1-one
- Polypeptides
- Dihydrofolate reductase
- Oligo-state
- monomer
|
| - SMTL ID
- 4ele.2
- Ligands
- CALCIUM ION; CHLORIDE ION; (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(propan-2-yl)phthalazin-2(1H)-yl]prop-2-en -1-one
- Polypeptides
- Dihydrofolate reductase
- Oligo-state
- monomer
|
| - SMTL ID
- 4ele.3
- Ligands
- CALCIUM ION; CHLORIDE ION; (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(propan-2-yl)phthalazin-2(1H)-yl]prop-2-en -1-one
- Polypeptides
- Dihydrofolate reductase
- Oligo-state
- monomer
|
| - SMTL ID
- 4ele.4
- Ligands
- CALCIUM ION; CHLORIDE ION; (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(propan-2-yl)phthalazin-2(1H)-yl]prop-2-en -1-one
- Polypeptides
- Dihydrofolate reductase
- Oligo-state
- monomer
|
| - SMTL ID
- 4ele.5
- Ligands
- CALCIUM ION; CHLORIDE ION; (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(propan-2-yl)phthalazin-2(1H)-yl]prop-2-en -1-one
- Polypeptides
- Dihydrofolate reductase
- Oligo-state
- monomer
|
| - SMTL ID
- 4ele.6
- Ligands
- CALCIUM ION; CHLORIDE ION; (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(propan-2-yl)phthalazin-2(1H)-yl]prop-2-en -1-one
- Polypeptides
- Dihydrofolate reductase
- Oligo-state
- monomer
|
| - SMTL ID
- 4ele.7
- Ligands
- CALCIUM ION; CHLORIDE ION; (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(propan-2-yl)phthalazin-2(1H)-yl]prop-2-en -1-one
- Polypeptides
- Dihydrofolate reductase
- Oligo-state
- monomer
|
| - SMTL ID
- 4ele.8
- Ligands
- (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(propan-2-yl)phthalazin-2(1H)-yl]prop-2-en -1-one; CALCIUM ION; CHLORIDE ION
- Polypeptides
- Dihydrofolate reductase
- Oligo-state
- monomer
|